Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
Dyne Therapeutics(DYN) Newsfilter·2024-05-22 08:39
Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this press release, including statements relating to the anticipated closing date of the public offering, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," ...